Chikh G - Search Results

1

Molecular attributes of conjugate antigen influence function of antibodies induced by anti-nicotine vaccine in mice and non-human primates.

McCluskie MJ, Thorn J, Mehelic PR, Kolhe P, Bhattacharya K, Finneman JI, Stead DR, Piatchek MB, Zhang N, Chikh G, Cartier J, Evans DM, Merson JR, Davis HL. McCluskie MJ, et al. Among authors: chikh g. Int Immunopharmacol. 2015 Apr;25(2):518-27. doi: 10.1016/j.intimp.2015.02.030. Epub 2015 Feb 28. Int Immunopharmacol. 2015. PMID: 25737198

2

Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.

Weeratna RD, Chikh G, Zhang L, Fraser JD, Thorn JM, Merson JR, McCluskie MJ, Champion BR, Davis HL. Weeratna RD, et al. Among authors: chikh g. Immun Inflamm Dis. 2016 Apr 1;4(2):135-147. doi: 10.1002/iid3.98. eCollection 2016 Jun. Immun Inflamm Dis. 2016. PMID: 27957325 Free PMC article.

3

Effects of KLK Peptide on Adjuvanticity of Different ODN Sequences.

Chikh G, Luu R, Patel S, Davis HL, Weeratna RD. Chikh G, et al. Vaccines (Basel). 2016 May 4;4(2):14. doi: 10.3390/vaccines4020014. Vaccines (Basel). 2016. PMID: 27153098 Free PMC article.

4

Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles.

Wilson KD, Raney SG, Sekirov L, Chikh G, deJong SD, Cullis PR, Tam YK. Wilson KD, et al. Among authors: chikh g. Int Immunopharmacol. 2007 Aug;7(8):1064-75. doi: 10.1016/j.intimp.2007.04.002. Epub 2007 May 2. Int Immunopharmacol. 2007. PMID: 17570323

5

Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif.

Jurk M, Chikh G, Schulte B, Kritzler A, Richardt-Pargmann D, Lampron C, Luu R, Krieg AM, Vicari AP, Vollmer J. Jurk M, et al. Among authors: chikh g. Nucleic Acid Ther. 2011 Jun;21(3):201-14. doi: 10.1089/nat.2011.0298. Nucleic Acid Ther. 2011. PMID: 21749297

6

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.

de Jong S, Chikh G, Sekirov L, Raney S, Semple S, Klimuk S, Yuan N, Hope M, Cullis P, Tam Y. de Jong S, et al. Among authors: chikh g. Cancer Immunol Immunother. 2007 Aug;56(8):1251-64. doi: 10.1007/s00262-006-0276-x. Epub 2007 Jan 23. Cancer Immunol Immunother. 2007. PMID: 17242927 Free PMC article.

7

The effect of circulation lifetime and drug-to-lipid ratio of intravenously administered lipid nanoparticles on the biodistribution and immunostimulatory activity of encapsulated CpG-ODN.

Raney SG, Wilson KD, Sekirov L, Chikh G, de Jong SD, Cullis PR, Tam YK. Raney SG, et al. Among authors: chikh g. J Drug Target. 2008 Aug;16(7):564-77. doi: 10.1080/10611860802228756. J Drug Target. 2008. PMID: 18686126

8

Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.

Chikh G, de Jong SD, Sekirov L, Raney SG, Kazem M, Wilson KD, Cullis PR, Dutz JP, Tam YK. Chikh G, et al. Int Immunol. 2009 Jul;21(7):757-67. doi: 10.1093/intimm/dxp044. Epub 2009 Jun 5. Int Immunol. 2009. PMID: 19502586

9

Methods for the preparation of protein-oligonucleotide-lipid constructs.

Takasaki J, Raney SG, Chikh G, Sekirov L, Brodsky I, Tam Y, Ansell SM. Takasaki J, et al. Among authors: chikh g. Bioconjug Chem. 2006 Mar-Apr;17(2):451-8. doi: 10.1021/bc050052j. Bioconjug Chem. 2006. PMID: 16536477

10

Liposomal delivery of CTL epitopes to dendritic cells.

Chikh G, Schutze-Redelmeier MP. Chikh G, et al. Biosci Rep. 2002 Apr;22(2):339-53. doi: 10.1023/a:1020151025412. Biosci Rep. 2002. PMID: 12428909 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters